Advertisement

Session Puts a Spotlight on Health Care Disruptors and Innovators

Despite its rising level of health care spending, the United States lags behind other countries in many outcomes and quality measures. Much of the...

AMCP Headline Session: Trends and Development in Pharmaceuticals

During a presentation at the AMCP Annual Meeting, Douglas M. Long, BS, MBA, vice president of industry relations at Iqvia in Ponte Vedra...

How to Address the Drug Coupon Challenge

The number of drugs with copay cards has soared in the past 10 years, from 75 drugs in 2009 to 700 drugs...

Best Practices for Navigating Preapproval Information Exchange

Preapproval information exchange is the communication between biopharmaceutical companies and population health decision-makers on topics such as phase III clinical trial data, pharmacoeconomic data,...

What Is the Role of an Actuary on Pharmacy Benefits?

An actuary is a business professional who deals with the measurement and management of risk and uncertainty, particularly compiling and analyzing statistics to calculate...

The OIG’s Proposed Change to Rebates and the Effect on Stakeholders

Manufacturers and payers, including managed care organizations, have been entering into agreements to discount drug prices in exchange for formulary placement, volume commitments, and...
Advertisement